|
Market Closed -
NYSE
04:00:02 11/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 159.64 USD | +1.72% |
|
-2.90% | +73.65% |
| 12:04am | Berenberg Notes AstraZeneca's 'Stellar' Tozorakimab Late-stage Data; Buy Retained | MT |
| 11:40pm | European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading | MT |
| Market Cap | 247B 212B 200B 182B 341B 23,587B 344B 2,384B 918B 11,964B 926B 906B 38,001B | P/E 2026 * |
20.4x | P/E 2027 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise Value | 266B 229B 216B 197B 368B 25,447B 371B 2,572B 990B 12,907B 999B 978B 40,996B | EV / Sales 2026 * |
4.2x | EV / Sales 2027 * | 3.86x |
| Free-Float |
96.63% | Yield 2026 * |
2.1% | Yield 2027 * | 2.24% |
Last Transcript : AstraZeneca PLC
| 1 day | +1.72% | ||
| Current month | +72.08% | ||
| Current year | +73.65% |
| Current year | 89.04 |  | 160.3 |
| 1 year | 72.9 | | 160.3 |
| 3 years | 60.47 | | 160.3 |
| 5 years | 52.65 | | 160.3 |
| 10 years | 25.55 | | 160.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 01/10/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 01/08/2021 |
Jeffrey Pott
CMP | Compliance Officer | - | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 01/10/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 27/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.72% | -2.90% | - | - | 245B | |
| -0.11% | -3.20% | +49.61% | +91.49% | 1,002B | |
| -0.27% | -3.22% | +50.51% | +65.89% | 644B | |
| +1.63% | -2.57% | +21.19% | +71.12% | 443B | |
| -0.63% | -1.06% | +28.11% | +34.59% | 343B | |
| +0.43% | -14.61% | +9.88% | +27.26% | 262B | |
| +0.93% | -1.82% | -1.82% | +8.41% | 245B | |
| -2.25% | -13.63% | +36.61% | +47.43% | 212B | |
| -0.90% | -5.09% | -15.47% | -57.75% | 199B | |
| -0.58% | -3.21% | +25.10% | +90.54% | 181B | |
| Average | +0.19% | -5.00% | +22.63% | +42.11% | 392.19B | |
| Weighted average by Cap. | +0.31% | -4.24% | +31.90% | +57.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.3B 54.44B 51.36B 46.79B 87.47B 6,052B 88.26B 612B 235B 3,070B 238B 233B 9,750B | 66.9B 57.53B 54.28B 49.45B 92.44B 6,396B 93.28B 646B 249B 3,244B 251B 246B 10,304B |
| Net income | 12.03B 10.34B 9.76B 8.89B 16.62B 1,150B 16.77B 116B 44.73B 583B 45.16B 44.17B 1,852B | 13.77B 11.84B 11.17B 10.18B 19.02B 1,316B 19.2B 133B 51.21B 668B 51.7B 50.57B 2,121B |
| Net Debt | 19.45B 16.73B 15.78B 14.38B 26.88B 1,860B 27.12B 188B 72.34B 943B 73.04B 71.44B 2,996B | 11.77B 10.12B 9.55B 8.7B 16.26B 1,125B 16.41B 114B 43.76B 571B 44.18B 43.22B 1,812B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | US$159.64 | +1.72% | 2,935,116 |
| 09/09/26 | US$156.94 | -1.94% | 3,874,039 |
| 08/09/26 | US$160.04 | -1.63% | 5,146,270 |
| 04/09/26 | US$162.70 | -1.26% | 3,073,349 |
| 03/09/26 | US$164.77 | +1.94% | 2,425,271 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
